ArticleJournal of bone metabolism2026
The Association between Sarcopenia and Chronic Kidney Disease among the Patients of Diabetes Mellitus: Korean National Health and Nutrition Examination Survey 2008-2011.
Article in Journal of bone metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to investigate the association between sarcopenia and chronic kidney disease (CKD) among diabetes mellitus (DM) patients.
methodsThe study used the data extracted from 1,855 patients collected by the Korean National Health and Nutrition Examination Surveys conducted in 2008-2011. Body mass index (BMI)-adjusted, weight-adjusted, and height2 -adjusted appendicular skeletal muscle mass were used to define sarcopenia, and the young reference group was analyzed for the cutoff values, which are 0.9 for men 0.6 for women in BMI-adjusted, 29.6 for men, and 23.3 for women in weight-adjusted, and 6.9 - men and 4.8 - women in height2-adjusted index. Participants were classified as having diabetes if they either presented with a fasting plasma glucose ≥126 mg/dL (7.00 mmol/L) or glycated hemoglobin ≥6.5% (48 mmol/moL) or provided any self-report of a physician's diagnosis or current treatment of diabetes. The equation developed by the CKD Epidemiology Collaboration was used to calculate the estimated glomerular filtration rate (eGFR). CKD was defined as having an eGFR less than 60 mL/min/1.73 m2. The association between sarcopenia and CKD was assessed using multiple logistic regression, adjusting for potential confounders.
resultsThe final analysis included 1,855 participants with diabetes. After adjusting for potential confounders, sarcopenia was significantly associated with an increased prevalence of CKD. Specifically, patients with sarcopenia had 1.826 times the odds of having CKD compared to those without sarcopenia (odds ratio, 1.826; 95% confidence interval, 1.092-3.054).
conclusionsThere is an association between sarcopenia and CKD in DM patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.